Insulin, Globin Zinc
Showing 26 - 50 of 8,892
Cystic Fibrosis Trial in Minneapolis, Saint Paul (novolog insulin, levemir insulin, )
Completed
- Cystic Fibrosis
- novolog insulin
- +2 more
-
Minneapolis, Minnesota
- +1 more
Aug 8, 2022
To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children Trial in
Completed
- To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children
- Glargine and regular insulin versus NPH and regular insulin
-
Lahore, Punjab, PakistanPediatric endocrine and diabetes section, Pediatric department,
Jan 29, 2023
Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)
Recruiting
- Diabetes Mellitus, Type 2 Treated With Insulin
- insulin degludec + liraglutide
- Insulin Glargine - Insulin Aspart
-
Bogotá, ColombiaHospital Universitario San Ignacio
Mar 2, 2023
Acne Scars - Mixed Atrophic and Hypertrophic Trial (microneedling with topical glycolic acid 35%., microneedling with topical
Not yet recruiting
- Acne Scars - Mixed Atrophic and Hypertrophic
- microneedling with topical glycolic acid 35%.
- microneedling with topical human insulin solution.
- (no location specified)
Oct 25, 2022
Glaucoma Trial in Palo Alto (Insulin, 4 units, Insulin, 20 units)
Recruiting
- Glaucoma
- Insulin, 4 units
- Insulin, 20 units
-
Palo Alto, CaliforniaByers Eye Institute at Stanford University
May 9, 2022
Diabetes, Type 1, Type 1 Diabetes Trial in Dhaka, Mwanza (Insulin Glargine, NPH or premixed 70/30 (human insulin))
Not yet recruiting
- Diabetes Mellitus, Type 1
- Type 1 Diabetes
- Insulin Glargine
- NPH or premixed 70/30 (human insulin)
-
Dhaka, Bangladesh
- +2 more
Nov 30, 2022
Critical Illness Trial in Leuven (intensive insulin therapy (Actrapid IV to normoglycemia), conventional insulin therapy
Active, not recruiting
- Critical Illness
- intensive insulin therapy (Actrapid IV to normoglycemia)
- conventional insulin therapy (Actrapid IV only for excessive hyperglycemia)
-
Leuven, BelgiumDep Intensive Care Medicine University Hospital Leuven
Mar 8, 2022
Diabetes, Type 2, NASH - Nonalcoholic Steatohepatitis Trial in Tustin, Jerusalem, Tel Aviv (ORMD-0801 (Insulin) capsule 8 mg BD,
Completed
- Diabetes Mellitus, Type 2
- NASH - Nonalcoholic Steatohepatitis
- ORMD-0801 (Insulin) capsule 8 mg BD
- Placebo
-
Tustin, California
- +2 more
Sep 13, 2022
NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects Blood
Enrolling by invitation
- Diabetes Mellitus, Type 1
- Insulin degludec
- Fast-acting insulin aspart
-
Bonheiden, Belgium
- +22 more
Dec 19, 2022
Type 2 Diabetes Trial in China (Insulin Degludec and Insulin Aspart Injection, Insulin Aspart Injection)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Insulin Degludec and Insulin Aspart Injection
- Insulin Aspart Injection
-
Shijiazhuang, Hebei, China
- +5 more
Jun 13, 2022
Diabetes Trial in Norwich (Automated closed-loop insulin delivery (AiD), A standard insulin delivery system)
Active, not recruiting
- Diabetes
- Automated closed-loop insulin delivery (AiD)
- A standard insulin delivery system
-
Norwich, Norfolk, United KingdomNorfolk and Norwich University Hospitals NHS Foundation Trust
Nov 4, 2022
Insulin Trial in Baton Rouge (Insulin, Regular, Human, Placebo)
Active, not recruiting
- Insulin
- Insulin, Regular, Human
- Placebo
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Aug 16, 2022
Healthy, Vasodilation, Insulin Resistance Trial in Columbia (Carbon dioxide breathing, Neurovascular Coupling, Human insulin)
Recruiting
- Healthy
- +3 more
- Carbon dioxide breathing
- +2 more
-
Columbia, MissouriUniversity of Missouri
Feb 3, 2022
Type 2 Diabetes Trial in India (INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010), INSULIN GLARGINE (HOE901), Metformin)
Completed
- Type 2 Diabetes Mellitus
- INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010)
- +3 more
-
Bangalore, India
- +12 more
Apr 21, 2022
Diabetes Trial (insulin iontophoresis, topical insulin, conventional treatment)
Not yet recruiting
- Diabetes Mellitus
- insulin iontophoresis
- +2 more
- (no location specified)
Jul 1, 2022
Diabetes, Type 1, Diabetes, Type 2 Trial in China (Faster aspart, Insulin aspart, Insulin degludec)
Completed
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Faster aspart
- +2 more
-
Hefei, Anhui, China
- +34 more
Nov 3, 2022
Type 1 Diabetes Trial in Loma Linda, Austin (Afrezza (insulin human) Inhalation Powder, insulin degludec, Continuous
Recruiting
- Type 1 Diabetes
- Afrezza (insulin human) Inhalation Powder
- +2 more
-
Loma Linda, California
- +1 more
Apr 12, 2022
Diabetes Trial in Chengdu (INS062 injection, Insulin Aspart, HR20014 injection)
Recruiting
- Diabetes
- INS062 injection
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Feb 8, 2023
Postoperative Neurocognitive Disorders Trial in Xi'an (Intranasal insulin, Intranasal saline)
Recruiting
- Postoperative Neurocognitive Disorders
- Intranasal insulin
- Intranasal saline
-
Xi'an, Shannxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Nov 6, 2022
Type1 Diabetes Trial in Neuss (Insulin glulisine (U300), Insulin glulisine, Insulin aspart)
Completed
- Type1 Diabetes Mellitus
- Insulin glulisine (U300)
- +6 more
-
Neuss, GermanyInvestigational Site Number 276001
Apr 21, 2022
Injection, Blood Glucose, High, Glycemic Control Trial in Guangzhou (Needle-free injection device, Then traditional insulin pen,
Recruiting
- Injection
- +3 more
- Needle-free injection device, Then traditional insulin pen
- Traditional insulin pen , Then Needle-free injection device
-
Guangzhou, Guangdong, ChinaNanfang Hospital, southern medical university
May 23, 2022
Type 1 Diabetes Trial in San Francisco (Extended bolus of insulin then standard bolus of insulin, Standard bolus of insulin then
Not yet recruiting
- Type 1 Diabetes
- Extended bolus of insulin then standard bolus of insulin
- Standard bolus of insulin then extended bolus of insulin
-
San Francisco, CaliforniaUniversity of California San Francisco
Jul 8, 2022
Diabetic Ketoacidosis Trial in Baltimore (Early administration of subcutaneous insulin glargine dose, IV insulin infusion, IV
Completed
- Diabetic Ketoacidosis
- Early administration of subcutaneous insulin glargine dose
- +2 more
-
Baltimore, MarylandUniversity of Maryland Medical Center
Mar 19, 2022
Type 1 Diabetes Trial in Seongnam-si, Seoul (DIA:CONN G8 insulin pump, Multiple daily insulin injection)
Recruiting
- Type 1 Diabetes
- DIA:CONN G8 insulin pump
- Multiple daily insulin injection
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +1 more
Feb 15, 2022